Stoke Therapeutics, Inc. (STOK)
31.82
-0.36
(-1.12%)
USD |
NASDAQ |
Dec 30, 16:00
31.26
-0.56
(-1.76%)
Pre-Market: 09:13
Stoke Therapeutics Total Assets (Quarterly): 360.26M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.21B |
| Janux Therapeutics, Inc. | 1.025B |
| Insmed, Inc. | 2.361B |
| Aldeyra Therapeutics, Inc. | 77.80M |
| Mirum Pharmaceuticals, Inc. | 785.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.16M |
| Shareholders Equity (Quarterly) | 308.10M |
| Debt to Equity Ratio | 0.0155 |
| Current Ratio | 6.529 |
| Net Debt Paydown Yield | 0.02% |